CS MEDICA engages a Financial Advisor
CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that the Company has entered into an agreement with the financial advisor Kapital Partner in Denmark. With this cooperation, the company secures valuable insights and guidance on financial decisions and strategies as well as assistance in sourcing financial partners and maximizing shareholder value.As an efficient OTC alternative, CS MEDICA is currently first mover to bridge R&D with patent-pending products registered as medical devices with cannabidiol under the pharmaceutical regulation, Medical Device Directive (MDD), now